Kairos Pharma Ltd KAPA

US Biotechnology

$0.31 ▲ +2.07% (+$0.01)

⬆️ Above Yest. High 🗓️ Earnings Next Week

Open $0.32

Prev Close $0.30

Day Range $0.29 – $0.33

52W Range $0.27 – $2.11

Market Cap $6.55M

Beta 2.57

EPS (TTM) $-0.30

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NYSE MKT LLC
Currency	USD
IPO Date	2024-09-16
Shares Out.	21,410,000
Website	kairospharma.com ↗
Phone	18184045541
Employees	1
Net Income	-$1.7M
Total Assets	$5.7M
Total Liabilities	$431,000
Equity	$5.3M

About Kairos Pharma Ltd

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.

Kairos Pharma Ltd is a publicly traded company under the ticker symbol KAPA on the NYSE MKT LLC, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.